Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Moderna begins Phase 3 trials of its COVID-19 vaccine candidate
The randomised, placebo-controlled trial is expected to include approximately 30,000 participants in the US
PLI scheme guidelines evoke mix reviews from industry
Some laud the measures taken by the government while others list aspects that should have been considered under the scheme's…
Alembic Pharma gets approval from its board to raise up to Rs 1,000 crore via QIP
On May 22, the company's board had passed an enabling resolution to raise up to Rs 1,200 crore by issue of securities
SII enrols 6000 subjects for efficacy trial of rBCG vaccine, VPM1002 against COVID-19
The DBT-BIRAC supported trial aims to evaluate the ability of VPM1002 in reducing infection incidence and severe disease outcomes…
Govt announces guidelines to set up parks for bulk drugs and med devices
The government has opted for challenges mode to ensure the most attractive investment regime
Map of ammonium’s journey may prevent infection
By improving our understanding of the normal function of ammonium transporters, we can gain insight into how specific malfunctions…
DRL receives US FDA’s approval for XEGLYZETM (abametapir) lotion
XEGLYZE is indicated for the topical treatment of head lice infestation in patients 6 months of age and older
Health ministry decides against including Itolizumab in clinical management protocols for COVID-19
The permission to market the drug was granted for the treatment of cytokine release syndrome in 'moderate' to 'severe' Acute…
Moderna gets further $472 million US award for coronavirus vaccine development
The US-based drug maker said the additional funding will support its late-stage clinical development including the expanded Phase…
Scientists decode how coronavirus molecules camouflage in host cell
According to the researchers, this development may pave the way for the design of new drugs against the novel coronavirus…